In vitro anti-inflammatory activity of lignans isolated from Magnolia fargesii

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 3, 2009, Pages 937-940

  Kim, Jae Yeon ^a   Lim, Hyo Jin ^a   Lee, Da Yeon ^a   Kim, Ji Sun ^a   Kim, Do Hee ^a   Lee, Hwa Jin ^a   Kim, Hee Doo ^a   Jeon, Raok ^a   Ryu, Jae Ha ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Magnolia fargesii; Microglia; Nitric oxide; Prostaglandin E2

Indexed keywords

EPIMAGNOLIN B; EUDESMIN; LIGNAN; MAGNOLIN; NITRIC OXIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; YANGAMBIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; FLOWER; IN VITRO STUDY; MAGNOLIACEAE; MICROGLIA; NONHUMAN; PARKINSON DISEASE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2; HUMANS; I-KAPPA B PROTEINS; LIGNANS; LIGNIN; MAGNETIC RESONANCE SPECTROSCOPY; MAGNOLIA; NEURONS; NITRIC OXIDE; PLANT EXTRACTS; TRANSCRIPTION FACTOR RELA;

MAGNOLIA FARGESII; MAGNOLIACEAE;

EID: 58549094899     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.11.103     Document Type: Article

References (41)

1. Steuuhr D.J. Ann. Rev. Pharmacol. Toxicol. 37 (1997) 339
2. Alderton W.K., Cooper C.E., and Knowles R.G. Biochem. J. 357 (2001) 593
3. Chabrier P.E., Demerle-Pallardy C., and Auguet M. Cell. Mol. Life Sci. 55 (1999) 1029
4. MacMicking J., Xie Q.W., and Nathan C. Annu. Rev. Immunol. 15 (1997) 323
5. Nathan C. FASEB J. 6 (1992) 3051
6. Cuzzocrea S., Chatterjee P.K., Mazzon E., McDonald M.C., Dugo L., Di Paola R., Serraino I., Britti D., Caputi A.P., and Thiemermann C. Eur. J. Pharmacol. 453 (2002) 119
7. Hussain S.P., Hofseth L.J., and Harris C.C. Nat. Rev. Cancer 3 (2003) 276
8. Lehner M.D., Marx D., Boer R., Strub A., Hesslinger C., Eltze M., Ulrich W.R., Schwoebel F., Schermuly R.T., and Barsig J. J. Pharmacol. Exp. Ther. 317 (2006) 181
9. Colton C.A., Vitek M.P., Wink D.A., Xu Q., Cantillana V., Previti M.L., Van Nostrand W.E., Weinberg J.B., and Dawson H. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 12867
10. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7240
11. Rimarachin J.A., Jacobson J.A., Szabo P., Maclouf J., Creminon C., and Weksler B.B. Arterioscler. Thromb. 14 (1994) 1021
12. McGeer P.L., and McGeer E.G. Muscle Nerve 26 (2002) 459
13. Pawate S., Shen Q., Fan F., and Bhat N.R. J. Neurosci. Res. 77 (2004) 540
14. Pocock J.M., and Liddle A.C. Prog. Brain Res. 132 (2001) 555
15. Gibbons H.M., and Dragunow M. Brain Res. 1084 (2006) 1
16. Acarin L., Peluffo H., Gonzalez B., and Castellano B. J. Neurosci. Res. 68 (2002) 745
17. Choi S.H., Joe E.H., Kim S.U., and Jin B.K. J. Neurosci. 23 (2003) 5877
18. Namba T. Coloured Illustrations of Wakan-Yaku (Crude Drugs in Japan China and Neighboring Countries) Vol. II (1980), Hoikusha Publishing, Osaka
19. Kimura M., Suzuki J., Yamada T., Yoshizaki M., Kikuchi T., Kadota S., and Matsuda S. Planta Med. 51 (1985) 291
20. Kim H.M., Yi J.M., and Lim K.S. Pharmacol. Res. 39 (1999) 107
21. Kobayashi S., Kobayashi H., Matsuno H., Kimura I., and Kimura M. Immunopharmacology 39 (1998) 139
22. Kimura M., Kobayashi S., Luo B., and Kimura I. Int. Arch. Allergy Appl. Immunol. 93 (1990) 365
23. Chen C.C., Huang Y.L., Chen H.T., Chen Y.P., and Hsu H.Y. Planta Med. 54 (1988) 438
24. Jung K.Y., Kim D.S., Oh S.R., Park S.H., Lee I.S., Lee J.J., Shin D.H., and Lee H.K. J. Nat. Prod. 61 (1998) 808
25. Pan J.-X., Hensens O.D., Zink D.L., Chang M.N., and Hwang S.-B. Phytochemistry 26 (1987) 1377
26. Ahn K.S., Jung K.Y., Kim J.H., Oh S.R., and Lee H.K. Biol. Pharm. Bull. 24 (2001) 1085
27. 3CN 1.0 mL/min, UV 254 nm) eluting as a single peak at 7.4, 8.0, 8.4 and 8.7 min, respectively. The structures of compounds were identified by the analysis of Mass, NMR spectroscopic data.
28. Miyazawa M., Kasahara H., and Kameoka H. Phytochemistry 39 (1995) 1027
29. Ahmed A.A., Mahmoud A.A., Ali E.T., Tzakou O., Couladis M., Mabry T.J., Gati T., and Toth G. Phytochemistry 59 (2002) 851
30. Xu G.H., Kim J.A., Park S.H., Son A.R., Chang T.S., Chang H.W., Chung S.R., and Lee S.H. Kor. J. Pharmacog. 35 (2004) 152
31. Hofer O., and Schoelm R. Tetrahedron 37 (1981) 1181
32. Kakisawa H., Chen Y.P., and Hsu H.Y. Phytochemistry 11 (1972) 2289
33. Greger H., and Hofer O. Tetrahedron 36 (1980) 3551
34. 7, 416.1835).
35. Matsushita H., Miyase T., and Ueno A. Phytochemistry 30 (1991) 2025
36. Pelter A., Ward R.S., Rao E.V., and Sastry K.V. Tetrahedron 32 (1976) 2783
37. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Anal. Biochem. 126 (1982) 131
38. - concentration in culture supernatant. Samples (100 μL) of culture media were incubated with a 150 μL of Griess reagent (1% sulfanilamide, 0.1% naphthylethylene diamine in 2.5% phosphoric acid solution) at room temperature for 10 min in 96-well microplate. Absorbance at 540 nm was read using an ELISA plate reader. Standard calibration curves were prepared using sodium nitrite as standard.
39. Youn H.S., Lim H.J., Lee H.J., Hwang D., Yang M., Jeon R., and Ryu J.-H. Biosci. Biotechnol. Biochem. 72 (2008) 368
40. Kim Y.J., Ryu J.-H., Cheon Y.J., Lim H.J., and Jeon R. Bioorg. Med. Chem. Lett. 17 (2007) 3317
41. Minghetti L., and Levi G. Prog. Neurobiol. 54 (1998) 99